These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 1451372)
21. [Hormone replacement in patients at high risk for thromboses]. Hiller F Internist (Berl); 1997 Oct; 38(10):999-1000. PubMed ID: 9432514 [No Abstract] [Full Text] [Related]
23. [Social medicine aspects of pre- and postmenopause]. Schmeiser-Rieder A; Concin H; Schwarz B; Kunze M Wien Med Wochenschr; 1995; 145(14):331-3. PubMed ID: 7483647 [TBL] [Abstract][Full Text] [Related]
25. [Changes in AT-III following hormone therapy of females in the climacteric]. Enzelsberger H; Heytmanek G; Kurz C; Metka M Gynakol Rundsch; 1989; 29 Suppl 2():422-4. PubMed ID: 2613068 [No Abstract] [Full Text] [Related]
26. [Hormone replacement therapy: curse or blessing?]. Schmidt M; Fink D; Lang U; Kimmig R Gynakol Geburtshilfliche Rundsch; 2006; 46(4):165. PubMed ID: 17068400 [TBL] [Abstract][Full Text] [Related]
28. [Climacteric disorders and the principles of hormone replacement therapy]. Smetnik VP Ter Arkh; 1995; 67(10):70-4. PubMed ID: 8779115 [No Abstract] [Full Text] [Related]
29. Menopausal hormone replacement: not necessarily routine. Guinan ME J Med Assoc Ga; 1994 Apr; 83(4):205-8. PubMed ID: 8006547 [No Abstract] [Full Text] [Related]
30. [Estrogens in menopause--therapy and prevention. I. Hormone substitution in climacteric and postmenopause]. Wuttke W Internist (Berl); 1996 Apr; 37(4):402-5. PubMed ID: 8655280 [No Abstract] [Full Text] [Related]
31. [Recommendations for estrogen and progestin replacement therapy in climacteric and postmenopause. 31. Professional Meeting of the Zurich Discussion Circle, October 2003]. Birkhäuser M; Braendle W; Keller PJ; Kiesel L; Kuhl H; Neulen J Gynakol Geburtshilfliche Rundsch; 2004 Oct; 44(4):258-64. PubMed ID: 15459525 [No Abstract] [Full Text] [Related]
32. Compliance with hormone replacement therapy: are women receiving the full impact of hormone replacement therapy preventive health benefits? Ravnikar VA Womens Health Issues; 1992; 2(2):75-80; discussion 80-2. PubMed ID: 1617309 [No Abstract] [Full Text] [Related]
33. [More damage than gain]. Glaeske G Kinderkrankenschwester; 2004 Apr; 23(4):144-5. PubMed ID: 16134646 [No Abstract] [Full Text] [Related]
35. [Postmenopausal hormone replacement therapy and cardiovascular risk: role of conjugated equine estrogens and medroxyprogesterone acetate]. Ortmann J; Traupe T; Vetter W; Barton M Praxis (Bern 1994); 2004 May; 93(21):904-14. PubMed ID: 15216975 [TBL] [Abstract][Full Text] [Related]
36. [The role of estradiol metabolites in prevention of cardiovascular diseases by hormone substitution in postmenopause]. Lippert TH; Seeger H; Mueck AO Zentralbl Gynakol; 1999; 121(10):467-72. PubMed ID: 10573819 [TBL] [Abstract][Full Text] [Related]
38. ["Menopause medicine" a growing discipline. Many questions on hormones and women's health are still unanswered]. von Schoultz B Lakartidningen; 2001 Jan; 98(5):412-6. PubMed ID: 11229081 [No Abstract] [Full Text] [Related]
39. [The climacteric and its hormonal treatment]. Gvorgiev DB Akush Ginekol (Sofiia); 1993; 32(1):36-40. PubMed ID: 8172347 [No Abstract] [Full Text] [Related]
40. [The current principles of the hormonal therapy of patients with the climacteric syndrome]. Gudkova MA Akush Ginekol (Mosk); 1994; (2):7-11. PubMed ID: 8017586 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]